R Mark Guinn

Title: R Mark Guinn: Innovator in Cancer Treatment

Introduction

R Mark Guinn is a notable inventor based in Mystic, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds useful in the treatment of cancer. With a total of 2 patents, his work is recognized for its potential impact on healthcare.

Latest Patents

Guinn's latest patents focus on the enantiomers of a specific compound, 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3H-imidazol-4-yl)-methyl]-4-[3-(3-hydroxy-3-methyl-but-1-ynyl)-phenyl]-1-methyl-1H-quinolin-2-one. These inventions relate to the enantiomers and prodrugs of this compound, which are useful in treating hyperproliferative diseases, including various cancers in mammals. The patents also detail processes for producing enantiomerically pure or optically enriched forms of the compound using continuous chromatography.

Career Highlights

R Mark Guinn is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to contribute to innovative solutions in cancer treatment, enhancing the company's portfolio in oncology.

Collaborations

Guinn has collaborated with notable colleagues, including Subramanian Sam Guhan and Karl K Ng. These collaborations have fostered a productive environment for research and development in the pharmaceutical sector.

Conclusion

R Mark Guinn's contributions to cancer treatment through his innovative patents and collaborations highlight his role as a significant inventor in the pharmaceutical industry. His work continues to pave the way for advancements in medical treatments.